---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-050906"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2024-05-01T23:59:59+00:00"
generated_at: "2026-06-03T02:42:49.217424+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Organovo furnishes May 2024 corporate presentation; no specific financial data disclosed

## Summary
- Company posted investor presentation on its website covering business overview and strategy.
- Presentation includes forward-looking statements and is current as of May 1, 2024.
- No material new information such as earnings, guidance, or clinical milestones were disclosed in the excerpt.

## SEC filing metadata
- accession: 0000950170-24-050906
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2024-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000095017024050906/0000950170-24-050906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000095017024050906/onvo-20240501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-050906
- JSON: https://secwatch.observer/filing/0000950170-24-050906.json
- Plain text: https://secwatch.observer/filing/0000950170-24-050906.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.